(NewsNation) — A once-daily oral pill helped people with obesity lower their weight by an average of 12% after 72 weeks, according to manufacturer Eli Lilly.

The results were observed in the pharmaceutical company's Phase 3 trial of orforglipron, a GLP-1 drug like Ozempic, that requires no injections and has no food or water restrictions.

More than 3,120 adults reduced their weight by an average of 27.3 pounds, the study showed.

Participants who saw results included those who used the highest dose of the pill, didn't have diabetes and were obese or overweight with at least one weight-related medical problem,

Lilly also manufactures Zepbound for obesity, and Mounjaro and Trulicity for diabetes.

Oral weight loss pill a good 'off-ramp' for injection users: Doctor

Dr. Sue Decotiis, a wei

See Full Page